Diagnosis and staging of pancreatic ductal adenocarcinoma
Clin. transl. oncol. (Print)
; 19(10): 1205-1216, oct. 2017. tab, ilus
Article
in English
| IBECS
| ID: ibc-166153
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
The management of pancreatic ductal adenocarcinoma (PDAC) is a major public health concern worldwide. Currently, most PDAC patients are diagnosed in advanced stages. The signs and symptoms of the disease, except for jaundice, are non-specific. Thus, the current challenge is to identify earlier those individuals for whom specific screening tools and specific treatments would be beneficial. On the basis of the recommendations of the group of experts of multiple medical specialties of the GALLgo Project, the patients with PDAC should be managed by a multidisciplinary team to assess the personal and family history, the best diagnostic and staging procedures and consider all important aspects for treatment decisions. In this article, the group of experts proposes strategies to shorten the diagnosis times in PDAC patients (AU)
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Biopsy
/
Abdominal Pain
/
Carcinoma, Pancreatic Ductal
/
Endoscopy
/
Neoplasm Staging
Type of study:
Diagnostic study
/
Practice guideline
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2017
Document type:
Article
Institution/Affiliation country:
Centro Anatomopatológico/Spain
/
Complejo Hospitalario de Granada/Spain
/
Hospital General Universitario de Alicante/Spain
/
Hospital Universitario Ramón y Cajal/Spain